Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma

Mansi A. Parasramka, Sayantan Maji, Akiko Matsuda, Irene K. Yan, Tushar Patel

Research output: Contribution to journalReview articlepeer-review

125 Scopus citations


The recognition of functional roles for transcribed long non-coding RNA (lncRNA) has provided a new dimension to our understanding of cellular physiology and disease pathogenesis. LncRNAs are a large group of structurally complex RNA genes that can interact with DNA, RNA, or protein molecules to modulate gene expression and to exert cellular effects through diverse mechanisms. The emerging knowledge regarding their functional roles and their aberrant expression in disease states emphasizes the potential for lncRNA to serve as targets for therapeutic intervention. In this concise review, we outline the mechanisms of action of lncRNAs, their functional cellular roles, and their involvement in disease. Using liver cancer as an example, we provide an overview of the emerging opportunities and potential approaches to target lncRNA-dependent mechanisms for therapeutic purposes.

Original languageEnglish (US)
Pages (from-to)67-78
Number of pages12
JournalPharmacology and Therapeutics
StatePublished - May 2016


  • Chemoresistance
  • Epigenetics
  • Gene regulation
  • Hepatocellular carcinoma
  • Long non-coding RNA
  • Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this